{"id":1229,"date":"2017-10-27T10:15:27","date_gmt":"2017-10-27T08:15:27","guid":{"rendered":"http:\/\/www.nanexa.com\/?p=1229"},"modified":"2017-10-27T10:15:27","modified_gmt":"2017-10-27T08:15:27","slug":"nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt","status":"publish","type":"post","link":"https:\/\/nanexa.com\/sv\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt\/","title":{"rendered":"Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt"},"content":{"rendered":"<p><strong>Uppsala 2017-10-27<\/strong><\/p>\n<p><strong>Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt inom onkologiomr\u00e5det.<\/strong><\/p>\n<p>M\u00e5ndagens st\u00e4mmobeslut att g\u00e5 vidare med den av styrelsen f\u00f6reslagna nyemissionen skapar de finansiella m\u00f6jligheterna f\u00f6r bolaget att p\u00e5b\u00f6rja och driva ett produktprojekt i egen regi. Strategin ut\u00f6kar m\u00f6jligheterna till framtida int\u00e4kter fr\u00e5n produktlicensiering, samtidigt som projektet succesivt kommer att ge v\u00e4rdefulla resultat f\u00f6r utlicensieringen av sj\u00e4lva teknologiplattformen PharmaShell\u00ae.<\/p>\n<p>Nanexa har identifierat onkologiomr\u00e5det som s\u00e4rskilt intressant och har redan kontakt med ett antal experter inom omr\u00e5det. Bolaget siktar p\u00e5 att under f\u00f6rsta halv\u00e5ret 2018 fatta inriktningsbeslut f\u00f6r projektet om val av specifik indikation och aktiv substans som matchar ett viktigt medicinskt behov och en betydande marknadspotential. Bolaget avser d\u00e4refter att dokumentera projektet prekliniskt och f\u00f6rbereda en f\u00f6rsta klinisk studie, att genomf\u00f6ra tillsammans med en partner eller i egen regi.<\/p>\n<p>\u201dDe nyligen erh\u00e5llna resultaten b\u00e5de fr\u00e5n utvecklingen av sj\u00e4lva teknologin och de goda djurstudieresultaten g\u00f6r att vi nu k\u00e4nner oss mogna att ta detta viktiga steg\u201d, s\u00e4ger Nanexas VD David Westberg.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>F\u00f6r ytterligare information:<\/strong><\/p>\n<p>Nanexa AB (publ)<\/p>\n<p>David Westberg, VD<\/p>\n<p>Tel. 0709-42 83 03<\/p>\n<p>E-mail: david.westberg@nanexa.se<\/p>\n<p>www.nanexa.com<\/p>\n<p>Om Nanexa AB (publ)<\/p>\n<p>Nanexa AB \u00e4r ett nanoteknologiskt drug delivery-f\u00f6retag som fokuserar verksamheten p\u00e5 utvecklingen av PharmaShell<sup>\u00ae<\/sup> som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom ett flertal indikationsomr\u00e5den. Inom ramen f\u00f6r PharmaShell<sup>\u00ae<\/sup> har Nanexa samarbetsavtal med bland andra AstraZeneca.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Uppsala 2017-10-27<\/p>\n<p>Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt inom onkologiomr\u00e5det.<\/p>\n<p>M\u00e5ndagens st\u00e4mmobeslut att g\u00e5 vidare med den av styrelsen f\u00f6reslagna nyemissionen skapar de finansiella m\u00f6jligheterna f\u00f6r bolaget att p\u00e5b\u00f6rja och driva ett produktprojekt i egen regi.<\/p>\n<p><a class=\"read-more\" href=\"https:\/\/nanexa.com\/sv\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt\/\">L\u00e4s mer<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[7],"tags":[],"class_list":["post-1229","post","type-post","status-publish","format-standard","hentry","category-nyheter"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Uppsala 2017-10-27 Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt inom onkologiomr\u00e5det. M\u00e5ndagens st\u00e4mmobeslut att g\u00e5 vidare med den av styrelsen f\u00f6reslagna nyemissionen skapar de finansiella m\u00f6jligheterna f\u00f6r bolaget att p\u00e5b\u00f6rja och driva ett produktprojekt i egen regi.L\u00e4s mer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta property=\"article:published_time\" content=\"2017-10-27T08:15:27+00:00\" \/>\n<meta name=\"author\" content=\"Anders Johansson\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anders Johansson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt\\\/\"},\"author\":{\"name\":\"Anders Johansson\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/person\\\/d26735c022a71d41737953c23a07692a\"},\"headline\":\"Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt\",\"datePublished\":\"2017-10-27T08:15:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt\\\/\"},\"wordCount\":274,\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"articleSection\":[\"Nyheter\"],\"inLanguage\":\"sv-SE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt\\\/\",\"name\":\"Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2017-10-27T08:15:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/person\\\/d26735c022a71d41737953c23a07692a\",\"name\":\"Anders Johansson\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"caption\":\"Anders Johansson\"},\"url\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/author\\\/anders\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt - Nanexa AB","og_description":"Uppsala 2017-10-27 Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt inom onkologiomr\u00e5det. M\u00e5ndagens st\u00e4mmobeslut att g\u00e5 vidare med den av styrelsen f\u00f6reslagna nyemissionen skapar de finansiella m\u00f6jligheterna f\u00f6r bolaget att p\u00e5b\u00f6rja och driva ett produktprojekt i egen regi.L\u00e4s mer","og_url":"https:\/\/nanexa.com\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt\/","og_site_name":"Nanexa AB","article_published_time":"2017-10-27T08:15:27+00:00","author":"Anders Johansson","twitter_card":"summary_large_image","twitter_misc":{"Skriven av":"Anders Johansson","Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanexa.com\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt\/#article","isPartOf":{"@id":"https:\/\/nanexa.com\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt\/"},"author":{"name":"Anders Johansson","@id":"https:\/\/nanexa.com\/#\/schema\/person\/d26735c022a71d41737953c23a07692a"},"headline":"Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt","datePublished":"2017-10-27T08:15:27+00:00","mainEntityOfPage":{"@id":"https:\/\/nanexa.com\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt\/"},"wordCount":274,"publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"articleSection":["Nyheter"],"inLanguage":"sv-SE"},{"@type":"WebPage","@id":"https:\/\/nanexa.com\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt\/","url":"https:\/\/nanexa.com\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt\/","name":"Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2017-10-27T08:15:27+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nanexa.com\/#\/schema\/person\/d26735c022a71d41737953c23a07692a","name":"Anders Johansson","image":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","caption":"Anders Johansson"},"url":"https:\/\/nanexa.com\/sv\/author\/anders\/"}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1229","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/comments?post=1229"}],"version-history":[{"count":1,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1229\/revisions"}],"predecessor-version":[{"id":1230,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1229\/revisions\/1230"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=1229"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/categories?post=1229"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/tags?post=1229"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}